References
- Shaharyar M, Siddiqui AA, Ali MA, Sriram D, Yogeeswari P. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3- (4′-hydroxy-3′-methylphenyl)-5-[(sub) phenyl]-2-pyrazolines. Bioorg Med Chem Lett 2006; 16: 3947–3949
- Shaharyar M, Siddiqui AA, Ali MA. Synthesis and evaluation of phenoxy acetic acid derivatives as a anti-mycobacterial agents. Bioorg Med Chem Lett 2006; 16: 4571–4574
- Shaharyar M, Siddiqui AA, Ali MA, Murugan V, Raghu C. Synthesis and cytotoxic activity of novel pyrazoline derivatives against human lung tumor cell line. J Chin Chem Soc 2007, (In press)
- Kucukguzel SG, Rollas S. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Farmaco 2002; 57(7)583–587
- Bekhit AA, Ashour HM, Guemei AA. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents. Arch: Pharm (Weinheim) 2005; 338(4)167–174
- Ruhoglu O, Ozdemir Z, Calis U, Gumusel B, Bilgin AA. Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines. Arzneimittelforschung 2005; 55(8)431–436
- Ucar G, Gokhan N, Yesilada A, Bilgin AA. 1N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases. Neurosci Lett 2005; 15: 327–331
- Rajendra Prasad Y, Lakshmana Rao A, Prasoona L, Murali K, Ravi Kumar P. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett 2005; 15: 5030–5034
- Turan Zitouni G, Ozdemir A, Guven K. Synthesis of some 1-[(N, N-disubstituted thiocarbamoyl thioacetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch Pharm (Weinheim) 2005; 338(2-3)96–104
- Amr Ael G, Abdel-Latif N-A, Abdalla MM. Synthesis and anti androgenic activity of some new 3-substituted androstano [17,16-c]-5′-aryl-pyrazoline and their derivatives. Bioorg Med Chem 2006; 15: 373–384
- De Clercq E, Descamps J, Verhelst G, Walker RT, Jones AS, Torrence P-F, Shugar D. Comparative efficacy of different antiherpes drugs against different strains of herpes simplex virus. J Infect Dis 1980; 141: 563–574
- De Clercq E, Holy A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986; 323: 464–467
- De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother 1985; 28: 84–89
- Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Meth 1988; 20: 309–321
- Balzarini J, Naesens L, Slachmuylders J, Niphuis H, Rosenberg I, Holy A, Schellekens H, De Clercq E. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS 1991; 5: 21–28
- Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clercq E, Broder S, Johns DG. The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3′-azido-2′,3′ dideoxythymidine and 2′,3′-dideoxy cytidine are highly dependent on the cell species. Pharmacol 1988; 37: 897–903
- Shahayar M, Siddiqui AA, Ali MA, Srinam D, Yogeeswari P. Bioorg Med Chem Lett 2006; 16: 3947–3949, Yar MS, Siddiqui AA, Ali MA, Bioorg Med Chem Lett 2006;16: 4571–74; Yar MS, Ali MA, Acta Pol Pharm 2006;6:491–496